Articles

National Influenza Vaccination Week took place from December 4th to the 10th, and the Centers for Disease Control and Prevention took advantage of this opportunity by stressing the importance flu vaccinations.

Gout is associated with a significantly increased risk of cancer, particularly prostate cancer in men, a recent study finds.

Chronic low back pain patients have a significantly increased comorbidity and health care cost burden, a new study finds.

Hyponatremia is a significant risk factor for falls in the elderly, finds a new study conducted by researchers at Texas Tech University Health Sciences Center in El Paso.

Last week, the FDA and FTC issued a press release which announced that seven companies which manufacture over-the-counter weight loss products containing human chorionic gonadotrpin have been asked to stop selling and marketing the unapproved drugs.

Many children with asthma lose control of their condition after discontinuing therapy with long-acting beta agonists, indicates a small-scale study conducted by researchers at the University of Louisville.

A prototype prostate cancer diagnostic test may aid urologists in determining patients who have a true negative biopsy result from patients who may suffer from occult cancer undetected by prostate biopsy and histopathologic review. Should a larger study confirm these preliminary findings, this test could spare 30% of men who require testing for cancer a repeat biopsy following a negative biopsy.

Knee pain associated with osteoarthritis has increased dramatically over the last few decades independent of age and body mass index, though radiographic osteoarthritis has not increased, a new study finds.

Over the past few years there has been an increasing amount of mobile technologies that enhance the ability to access public health information and improve the delivery of health services to the public at large, as well as to health care professionals. The ubiquity of cell phones makes SMS text messaging the natural platform to deliver these interventions.

When you think mHealth, you might immediately think of health care applications on your iPhone or an EMR on your tablet. But the process that led to that app to making it to your mobile device is a long and tedious one.

This morning’s session Harnessing the Power of Social Media and Mobile Technology to Engage Consumers at the mHealth Summit was a popular one, and with good reason. Social and mobile strategies in health care are becoming increasingly important and, when combined with gaming strategies, create what was described in the opening address as the "trifecta of effectiveness” when it comes to engaging patients.

In the afternoon session "mHealth at the Point of Care" at the mHealth Summit in National Harbor, MD, Bella Hwang spoke about an SMS program in Kenya that not only helped improve medication in AIDS patients, but also promised to do so in a highly economical way.

In a move that has been long anticipated by the diabetes community, the FDA has finally issued a draft guidance designed to aid investigators and manufacturers seeking approval for and developing "artificial pancreas" devices.

ADHD may be associated with deviations observed in genes which are connected to brain signaling pathways.

Radiofrequency treatment of patients with refractory gastroesophageal reflux disease appears to improve symptoms by decreasing compliance of the gastroesophageal junction, a new study suggests.

Healthcare is experiencing a myriad of changes in the administrative, legislative and technology pillars, with each contributing to the dynamic as we know it.

Horizon Pharma announced last Tuesday that the FDA had accepted its new drug application for Lodotra, a delayed-release formulation of low-dose prednisone, for treatment of rheumatoid arthritis in adults.

Several risk factors for chronic cerebrospinal venous insufficiency are also risk factors for multiple sclerosis, finds a new study.

Annual worldwide downloads of mHealth apps will be 44 million next year and reach 142 million by 2016, predicts a report released earlier this week by UK-based Juniper Reports.

The novel enzyme inhibitor combined with allopurinol demonstrated significantly better serum uric acid control than placebo plus allopurinol.